SATISFYER_1170x120_8-13-20

direct and indirect remuneration (DIR) fee reform

Pharmacy urges action to close DIR fee loophole

Pharmacy urges action to close DIR fee loophole

WASHINGTON – With the Senate Finance Committee holding a legislative markup today of the Prescription Drug Pricing Reduction Act (PDPRA) of 2019, eight associations noted initial bipartisan movement on direct and indirect remuneration (DIR) fee reform, but reiterated the need for swift and decisive action on this issue. Issuing a joint statement were: National Community

DIR fee reform highlights NACDS Regional

DIR fee reform highlights NACDS Regional

PALM BEACH – The National Association of Chain Drug Stores’ (NACDS) campaign-style approach to the issues crucial for pharmacy value and viability dominated today’s opening session of the 2019 NACDS Regional Chain Conference. NACDS’ top-priority issue of direct and indirect remuneration (DIR) fee reform headlined the discussion of the Association’s “Access Agenda” – which emphasizes